Mr. David Preiner reports

MEDIVOLVE ANNOUNCES TELEHEALTH PLATFORM DEVELOPMENT CONTRACT AND CHANGE OF OFFICERS AND DIRECTORS

Medivolve Inc. has entered into a master service agreement dated Dec. 29, 2023, with Engineer.ai Corp. (doing business as Builder.ai), to assist in the development of its telehealth platform. Pursuant to the agreement, Builder will develop robust features of the platform, including, but not limited to, provider and patient interfacing, telehealth video conferencing, appointment scheduling and management tools, credit card payment processing, and more. Features of the platform aim to additionally integrate through company API interfaces and third party API interfaces, all in compliance with HIPAA (Health Insurance Portability and Accountability Act). The company anticipates that development of the telehealth platform will be substantially complete within seven months.

Additionally, the company announces today that Aaron Atin, Daniyal Baizak and Peter Michel have resigned from their positions as corporate secretary, director and chief financial officer of the company, respectively, effective Jan. 10, 2024, Jan. 12, 2024, and Jan. 15, 2024. Mr. Atin will continue to support the company in his capacity as a consultant. The board and management thank Mr. Atin, Mr. Baizak and Mr. Michel for their services and contributions, and wish them well in their future endeavours.

About Medivolve Inc.

Medivolve is a Canadian health care technology company headquartered in Toronto, Canada. The company's mission is to improve health and lives by delivering world-class diagnostic solutions, starting with COVID-19, as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care locations in California.

We seek Safe Harbor.